Identifying responsiveness to radio-immuno combination therapy
A reactive, immunotherapeutic technique with applications in mechanical/radiation/invasive therapy, microbiological determination/inspection, computer-assisted medical procedures, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0025] A combination of radiation therapy and immunotherapy holds hope for a large number of patients battling advanced cancer. Described herein is an automated method that enables tailoring of tumor treatment by determining responsiveness based on biomarker expression in tumors, and identifies which should be selected for combined radio-immunotherapy treatment. An analysis of responsiveness to the available possible radiotherapy treatment modalities (eg, standard, accelerated, hypofractionated, ablative high-dose) is also described.
[0026]Recent studies have shown that hypofractionated radiation therapy can stimulate absitual responses (immune cell responses to tumor antigens) more effectively than high-dose single radiation therapy when combined with cytotoxic T lymphocyte antigen 4 (CTLA-4) immunotherapy. start up). A possible explanation for this finding is the finding that type I interferon (IFN-β) signaling derived from irradiated tumor cells is critical for BATF3-dep...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com